Freshpaint Healthcare Privacy Platform — martech.health

martech.health article on Freshpaint's Healthcare Privacy Platform and its alignment with HHS's updated HIPAA guidance on online tracking technologies.

HHS guidance context. On March 18, 2024, the US Department of Health and Human Services (HHS) updated its guidance on online tracking technologies and HIPAA compliance. The updated guidance explicitly called out Customer Data Platforms like Freshpaint as viable alternatives to web tracking technologies that do not support Business Associate Agreements (BAAs). Google and Facebook refuse to sign BAAs; their native tracking pixels are therefore in violation of HIPAA when used on sites that collect Protected Health Information (PHI).

What Freshpaint does. Freshpaint's Healthcare Privacy Platform replaces native web trackers with a BAA-supported platform. The platform:

• Automatically detects and blocks PHI before forwarding behavioral event data to downstream analytics and marketing tools.
• Uses ID masking: cryptographically hashes all user identifiers server-side using a secret salt, making hashes entirely irreversible.
• Creates anonymous visitor IDs to de-identify data before it reaches ad platforms.
• Maintains BAAs with downstream destinations, extending HIPAA coverage to the full analytics and marketing stack.

Market position. Freshpaint is described as a practical replacement for organizations that need HIPAA-compliant performance marketing — particularly healthcare providers and health-tech companies that previously relied on Google Analytics, Google Ads pixels, or Facebook Pixel for attribution and audience targeting.

Relevance to KG. Directly supports use-case.hipaa-safe-performance-marketing (OC-008) and the vendor.freshpaint candidate node. Provides non-vendor, non-investor corroboration for vendor.freshpaint's core claims.